Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anfibatide in NSTEMI patients
NCT01585259Phase 2Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Jul 2012
- Primary completion
- Dec 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of anfibatide in non-ST segment elevation myocardial infarction (NSTEMI), sponsored by Lee's Pharmaceutical Holdings Limited. Started Jul 2012; status: completed.
02
Drugs
anfibatide
03
Conditions
non-ST segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT01585259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01585259.